PL2694973T3 - Prognostyczny i terapeutyczny podpis dla czerniaka złośliwego - Google Patents

Prognostyczny i terapeutyczny podpis dla czerniaka złośliwego

Info

Publication number
PL2694973T3
PL2694973T3 PL12717232.8T PL12717232T PL2694973T3 PL 2694973 T3 PL2694973 T3 PL 2694973T3 PL 12717232 T PL12717232 T PL 12717232T PL 2694973 T3 PL2694973 T3 PL 2694973T3
Authority
PL
Poland
Prior art keywords
prognostic
malignant melanoma
signature
therapeutic
therapeutic signature
Prior art date
Application number
PL12717232.8T
Other languages
English (en)
Inventor
Stefanie Meyer
Anja Bosserhoff
Peter Wild
Thomas Fuchs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2694973T3 publication Critical patent/PL2694973T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/5743Specifically defined cancers of skin, e.g. melanoma
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12717232.8T 2011-04-01 2012-03-30 Prognostyczny i terapeutyczny podpis dla czerniaka złośliwego PL2694973T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11002747A EP2506015A1 (en) 2011-04-01 2011-04-01 A prognostic and therapeutic signature for malignant melanoma

Publications (1)

Publication Number Publication Date
PL2694973T3 true PL2694973T3 (pl) 2016-09-30

Family

ID=44343850

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12717232.8T PL2694973T3 (pl) 2011-04-01 2012-03-30 Prognostyczny i terapeutyczny podpis dla czerniaka złośliwego

Country Status (7)

Country Link
US (1) US20140094588A1 (pl)
EP (2) EP2506015A1 (pl)
AU (1) AU2012237286B2 (pl)
CA (1) CA2830450C (pl)
ES (1) ES2568753T3 (pl)
PL (1) PL2694973T3 (pl)
WO (1) WO2012131052A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10010504B2 (en) * 2013-03-15 2018-07-03 The Penn State Research Foundation Compositions and methods including celecoxib and plumbagin relating to treatment of cancer
US20150283237A1 (en) * 2014-04-02 2015-10-08 Mitchell S. Felder Ctla-4 blockade with metronomic chemotherapy for the treatment of cancer
US11515004B2 (en) 2015-05-22 2022-11-29 Csts Health Care Inc. Thermodynamic measures on protein-protein interaction networks for cancer therapy
GB201517528D0 (en) * 2015-10-02 2015-11-18 Julius Maximillians Universitãt Würzburg GDF-15 as a diagnosis marker for melanoma
CA3122502A1 (en) * 2017-12-21 2019-06-27 Board Of Regents, The University Of Texas System Enzyme-mediated depletion of adenosine and/or methylthioadenosine
CN110110906B (zh) * 2019-04-19 2023-04-07 电子科技大学 一种基于Efron近似优化的生存风险建模方法
CN115244175A (zh) 2020-01-07 2022-10-25 得克萨斯大学体系董事会 用于癌症治疗的改进的人甲硫腺苷/腺苷消耗酶变体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
US6080560A (en) 1994-07-25 2000-06-27 Monsanto Company Method for producing antibodies in plant cells
US7247426B2 (en) * 2001-08-02 2007-07-24 Agilent Technologies, Inc. Classifying cancers
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
EP2092075A2 (en) * 2006-11-06 2009-08-26 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring and treatment of melanoma
EP2162552A4 (en) 2007-05-11 2010-06-30 Univ Johns Hopkins BIOMARKERS FOR MELANOMES

Also Published As

Publication number Publication date
ES2568753T3 (es) 2016-05-04
WO2012131052A1 (en) 2012-10-04
EP2694973A1 (en) 2014-02-12
CA2830450A1 (en) 2012-10-04
US20140094588A1 (en) 2014-04-03
NZ615544A (en) 2015-09-25
EP2506015A1 (en) 2012-10-03
EP2694973B1 (en) 2016-02-03
AU2012237286A1 (en) 2013-10-03
CA2830450C (en) 2020-05-12
AU2012237286B2 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
EP2820520A4 (en) PRESSURE-SENSITIVE KEYS
HK1177020A1 (en) Edge gestures
EP2786329A4 (en) AUTHENTICATION OF LICENSE GRANT FOR APPLICATION
AP2014007430A0 (en) cryptographic
EP2596467A4 (en) EXPLORATION OF CREDIT RISKS
EP2674056A4 (en) PORTABLE BACKPACK PLATE FOR A LAPTOP
GB201223466D0 (en) Time-based authentication
EP2664261A4 (en) MILL
EP2691888A4 (en) SEGMENTS OF DEFINITION AND MATCHING
GB201101328D0 (en) A portable safe-room
PL2694973T3 (pl) Prognostyczny i terapeutyczny podpis dla czerniaka złośliwego
EP2791759A4 (en) HOUSING
EP2758925A4 (en) AD PLACEMENT
GB2494768B8 (en) Well pad placement
GB2500557B (en) Data encryption
EP2680376A4 (en) ROTARY USB INTERFACE DEVICE
EP2727307A4 (en) SOFTWARE AUTHENTICATION
GB201222586D0 (en) A portable lock
GB2505563B (en) Authentication information processing
GB2486292B (en) A security tape
SI2474256T1 (sl) Mlinček za začimbe z mlevnim mehanizmom
GB2509689B (en) A portable shower
SI2454978T1 (sl) Mlinček za začimbe
HK1214102A1 (zh) 面罩
HK1216042A1 (zh) 觸針